INTRODUCTION
============

The gastrointestinal tract of dairy goat presents an extensive surface area providing direct contact between the animal and a large assortment of nutrients, microbes and exogenous toxins. The intestine should permit the exchange of nutrients between the gut lumen and the systemic circulation, while preventing penetration of pathogenic organisms and toxic compounds ([@b24-ajas-29-6-814]). However, it had been documented that heat stress (HS) may cause injury to the intestinal epithelium ([@b2-ajas-29-6-814]; [@b9-ajas-29-6-814]) which leads to the entrance of bacterial endotoxin into the systemic circulation ([@b11-ajas-29-6-814]; [@b14-ajas-29-6-814]; [@b34-ajas-29-6-814]). The entrance of endotoxin in systemic circulation leads to a wide range of injuries including inflammation, damage of internal organs, disseminated intravascular coagulation, and even death ([@b11-ajas-29-6-814]; [@b23-ajas-29-6-814]). Therefore, preventing endotoxin absorption during HS may be greatly beneficial to animal health. [@b18-ajas-29-6-814] reported that the supplementation of yeast culture (YC) increased dry matter intake (DMI) and milk production of Holstein cows during HS. However, how YC achieves this effect is still unknown. It was reported that HS reduced the antioxidant capacity by reducing the activity of antioxidant enzymes ([@b15-ajas-29-6-814]), which increased the amount of free radicals ([@b10-ajas-29-6-814]; [@b25-ajas-29-6-814]), and the reduction of the antioxidant capacity was the main cause of injury to the gastrointestinal tract ([@b14-ajas-29-6-814]). On the other hand, vitamin E (VE) is a proven effective antioxidant. It is well documented VE is active in alleviating poultry HS ([@b3-ajas-29-6-814]; [@b4-ajas-29-6-814]). Although, whether VE alleviates HS in dairy goats is still unknown. Therefore, the objectives of this study were to evaluate and compare the effects of YC and VE supplementation on endotoxin absorption and antioxidant status in lactating dairy goats suffering from HS.

MATERIAL AND METHODS
====================

Animals and surgery
-------------------

All experimental procedures involving animals were approved by the Animal Care and Use Committee of Animal Nutrition Institute, Sichuan Agricultural University, and were carried out in accordance with the National Research Council's Guide for the Care and Use of Laboratory Animals.

Three lactating Saanen dairy goats (body weight 30±1.5 kg) were surgically fitted with indwelling catheters in the portal vein, the mesenteric vein and carotid artery. Portal vein catheters were silicone tube, and the 2 mesenteric catheters were made of Tygon. Two mesenteric venous catheters were inserted into branches between the major venous arch and the small intestine, one for sampling and the other for para-aminohippurate infusion. The establishment of catheters (portal vein and mesenteric vein) was described by [@b20-ajas-29-6-814]. Surgically peel off the truncus vagosympathicus which is concomitant to the right carotid, and then the carotid was wrapped and sealed in skin by stitch. Carotid catheter was inserted into the dissociative carotid one day before sampling.

Experimental design and feeding management
------------------------------------------

The animals were housed in individual metabolic cages in a temperature and humidity-controlled house with *ad libitum* access to water and were hand milked twice daily. The goats were fed a basal diet during the preliminary period. After a 2-wk preliminary period the three goats were randomly assigned to a 3×3 Latin square design. The 3 dietary treatments were basal diet (Control), basal diet supplemented with 100 IU VE, and basal diet supplemented with 30 g Original XPTM (A kind of YC, the product of Diamond V Biological Fermentation Engineering & Technologies Shenzhen Co., Ltd., Shenzhen, Guangdong, China). Each period lasted 14 days and the animals were fed the experimental diets. During the 2-wk of each period, the last 4 days were for sample collection. Basal diet was fed twice daily in equal amounts. VE and YC were supplemented at 8:00. The formulation of the basal diet was summarized in [Table 1](#t1-ajas-29-6-814){ref-type="table"}. The room temperature during experiment period was 35°C from 8:00 to 20:00 and 24°C from 20:00 till the next morning at 8:00. The relative humidity kept stable (55%). Feed intake was recorded daily.

Sampling and analyses
---------------------

Each sample collection period last 4 days. On the eleventh day of experiment, a continuous mesenteric venous infusion of para-aminohippurate (15 mg/mL formulated according to [@b21-ajas-29-6-814]) was initiated via the distal mesenteric vein catheter to determine portal and mesenteric venous blood flows. Continuous infusion was performed by using a HL-2B calibrated syringe pump (Made in Lanngue Instrument Company, Shijiazhuang, China) with a speed of 12 mg para-aminohippurate per min (0.8 mL/min). The infusion commenced at 13:00, 2 h after which a spot sampling procedure was administrated. A total of 12 spot samplings were performed at 1 h intervals. At each sampling spot, simultaneous arterial, portal and mesenteric venous blood samples were collected (5 mL for each sample) and were slowly dropped into a cuvette containing heparin (200 IU/mL). Samples were centrifuged at 1,500 rpm for 15 min at 4°C. Serum was frozen at −20°C for further analyses.

The para-aminohippurate concentration of plasma was determined according to [@b21-ajas-29-6-814]. Plasma concentration of superoxide dismutase (SOD), total antioxidant potential (TAP) and malonaldehyde (MDA) were measured using the methods of xanthine oxidation, ferric reducing/antioxidant power, and thiobarbituric acid, respectively. Reagent kits were bought from Jiancheng Bioengineering Institute, Nanjing, China. Plasma endotoxin concentration was determined by kinetic turbidimetric assay ([@b35-ajas-29-6-814]), using reagent kit bought from Xiamen tachypleus amebocyte lysate Co. LTD, Xiamen, China. The brief description of the procedure is: The standard endotoxin (*E. coli* 0111: B4) was dissolved in pyrogen-free distilled water. A BECKMAN VIS-723 Spectrophotometer (Beckman Coulter, Inc., Brea, CA, USA) was used and the absorbance of different concentrations of endotoxin dilutions at 545 μm were recorded. The absorbance data was used as the ordinate and the endotoxin concentrations as the abscissa to establish standard curve. The plasma samples were pretreated with moderate heating. Then 0.2 mL pyrogen-free water and 0.2 mL Tris-Hcl was added to 0.1 mL plasma and mixed, the mixture was placed into 100°C water bath for 10 min, centrifuged for 10 min (3,000 rpm), then 0.1 mL supernatant was taken for further determination. Next, 0.05 mL Limulus amebocyte lysate was added to the supernatant and mixed, and the tube placed into 37°C water bath for 25 min, and then 0.05 mL shark tripeptide was added and placed into 37°C water bath for 3 min, and 0.05 mL houjiaruya nitrate solution added and mixed, then 0.5 mL amino acid amine added and mixed, and finally added 0.5 mL benzathine. The absorbance of the mixture at 545 μm was recorded. The endotoxin concentration could be obtained using the standard curve.

Rectum temperature and respiration frequency
--------------------------------------------

Rectum temperature and respiration frequency were measured at 16:00, 18:00, 20:00, 22:00, 24:00, 02:00 on the 4th day of each period. Rectum temperature was measured by inserting thermometer into anus for 3 cm, and respiration frequency was calculated by counting the undulant times of flank within certain time slot measured by stopwatch.

Parameters calculation
----------------------

Portal and mesenteric venous blood flows were calculated from the following equations respectively:
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Net fluxes of endotoxin across portal-and mesenteric-drained viscera were calculated from the following equations:
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Net fluxes of antioxidants (including TAP, SOD, and MDA across portal-and mesenteric-drained viscera were calculated from the following equations:
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Statistical analyses
--------------------

The MIXED model Y~ij~ = μ+T~i~+e~ij~ of SAS ([@b28-ajas-29-6-814]) was used to analyze all of the data, where Y~ij~ is an observation on the dependent variable ij, μ is the overall population mean, T~i~ is the fixed effect of treatments (VE vs YC), e~ij~ is the random error associated with the observation ij. The data of plasma flux rate, endotoxin concentration in the portal vein and carotid, endotoxin absorption in the portal vein, plasma concentration of SOD, TAP, and MDA across different time spots were also analyzed using the same model, where the T~i~ is the fixed effect of different time spots. When significant differences (p\<0.05) were detected, post-hoc analyses were carried out using least significant difference test to compute pairwise differences in the means. Means with different superscript letter groups were obtained with PDMIX 800 SAS macro (SAS, Cary, NC, USA). Data were presented as mean±standard deviation.

RESULTS
=======

Dry matter intake
-----------------

The effect of supplementation YC and VE on the DMI of dairy goats is reported in [Table 2](#t2-ajas-29-6-814){ref-type="table"}. Feed intake of goats did not differ among treatments during the whole experiment period (p = 0.402).

Rectum temperature and respiration frequency
--------------------------------------------

Rectum temperature of the goats in the 3 treatments did not differ from each other (p = 0.125) during HS period, and decreased significantly (p\<0.01) when ambient temperature dropped from 35°C to 24°C ([Figure 1a](#f1-ajas-29-6-814){ref-type="fig"}). During thermo-neutral period, rectum temperature of the goats in VE and YC treatments kept on falling. Rectum temperature of the goats in YC treatment did not differ (p = 0.478) from VE treatment from 20:00 to 24:00, but greater (p\<0.05) than VE treatment from 24:00 to 02:00 ([Figure 1](#f1-ajas-29-6-814){ref-type="fig"}). Average rectum temperature of the goats during thermo-neutral period in the control was similar (p = 0.096) as that in YC treatment, and was greater (p\<0.05) than VE treatment ([Table 3](#t3-ajas-29-6-814){ref-type="table"}). There was no difference (p = 0.329) among the 3 treatments on rectum temperature during HS period and during the whole experiment period ([Table 3](#t3-ajas-29-6-814){ref-type="table"}). Respiration frequency of the goats in the 3 treatments kept stable from 16:00 to 20:00, and dropped significantly (p\<0.01) when ambient temperature decreased from 35°C to 24°C ([Figure 1b](#f1-ajas-29-6-814){ref-type="fig"}). Average respiration frequency of the goats in the 3 treatments during thermo-neutral period (p = 0.205), HS period (p = 0.224), and the whole experiment period (p = 0.897), was not different from each other ([Table 3](#t3-ajas-29-6-814){ref-type="table"}).

Plasma flux rate
----------------

There was no significant difference (p\>0.05) in the rate of plasma flux of the goats among the 3 treatments during HS period (15:00 to 20:00) ([Figure 2](#f2-ajas-29-6-814){ref-type="fig"}). However, with the prolonged HS, plasma flux rate in portal vein kept on decreasing. When the ambient temperature decreased from 35°C to 24°C, plasma flux rate of the goats in 3 treatments increased significantly (p\<0.01). The average plasma flux rate of the goats did not differ among treatments during thermo-neutral period (p = 0.769), HS period (p = 0.717), and the whole experiment period (p = 0.863) ([Table 4](#t4-ajas-29-6-814){ref-type="table"}).

Endotoxin concentration and absorption
--------------------------------------

Endotoxin concentration in the portal vein and carotid of the goats kept stable from 15:00 to 20:00 (HS period) within each treatment, and decreased (p\<0.01) sharply after 21:00 ([Figure 3a,b](#f3-ajas-29-6-814){ref-type="fig"}). The endotoxin concentration in the portal vein and carotid of the goats during HS period was the highest in the control (p\<0.01), followed by YC treatment (p\<0.05), and the lowest in VE treatment (p\<0.01). However it was not different during thermo-neutral period (p = 0.175 for portal vein, and p = 0.185 for carotid) among the 3 treatments ([Table 5](#t5-ajas-29-6-814){ref-type="table"}).

The endotoxin absorption was the highest (p\<0.01) in the control treatment and lowest (p\<0.01) in VE treatment at any time spot ([Figure 3c](#f3-ajas-29-6-814){ref-type="fig"}). The maximum absorption of endotoxin in the three treatments happened at 21.00, followed by 22.00, significantly greater (p\<0.01) than any other time spot ([Table 5](#t5-ajas-29-6-814){ref-type="table"}). The average endotoxin absorption during the whole experiment period and during HS period was the highest (p\<0.01) in the control and lowest (p\<0.01) in VE treatment, but it was not different (p = 0.161) among the 3 treatments during thermo-neutral period ([Table 5](#t5-ajas-29-6-814){ref-type="table"}).

Antioxidants concentrations in portal vein
------------------------------------------

Plasma concentration of SOD in portal vein in the control kept stable from 15:00 to 02:00 the next day, except for time spot (20:00), while the VE treatment kept stable before 19:00 and increased (p\<0.01) significantly from 23:00 ([Figure 4a](#f4-ajas-29-6-814){ref-type="fig"}). Plasma concentration of TAP in portal vein kept stable within each treatment, except for few prominent time spots ([Figure 4b](#f4-ajas-29-6-814){ref-type="fig"}). Across treatments, plasma concentration of TAP in portal vein was the highest (p\<0.01) in VE and the lowest (p\<0.01) in the control at any time spots ([Figure 4b](#f4-ajas-29-6-814){ref-type="fig"}). Plasma concentration of MDA in the portal vein of the goats kept stable across any time spots within each treatment, except for that at 21:00 ([Figure 4c](#f4-ajas-29-6-814){ref-type="fig"}). Plasma MDA concentration was always the highest (p\<0.01) in the control and the lowest (p\<0.01) in VE treatment ([Figure 4c](#f4-ajas-29-6-814){ref-type="fig"}).

The average plasma concentration of TAP in portal vein was the highest (p\<0.01) in VE and the lowest (p\<0.01) in the control during HS period ([Table 6](#t6-ajas-29-6-814){ref-type="table"}). The average plasma concentration of TAP in portal vein in the control was significantly lower (p\<0.05) than VE treatment, and the YC treatment was not significantly different from the control (p = 0.06) and VE (p = 0.479) treatment during thermo-neutral period ([Table 6](#t6-ajas-29-6-814){ref-type="table"}). The average plasma concentration of TAP during the whole experiment period in the control did not differ (p = 0.089) from the YC treatment, but was significantly lower than VE treatment (p\<0.01) ([Table 6](#t6-ajas-29-6-814){ref-type="table"}).

The average plasma concentration of SOD in VE and YC treatment during HS period was significantly lower (p\<0.01) than the control during HS period and whole experiment period, while no significant difference was observed between VE and YC treatments ([Table 6](#t6-ajas-29-6-814){ref-type="table"}). The SOD concentration of VE treatment was significantly lower than the control during the thermo-neutral period (p\<0.01) ([Table 6](#t6-ajas-29-6-814){ref-type="table"}).

Plasma MDA concentration during HS period and the whole experiment period was the highest (p\<0.01) in the control treatment, followed (p\<0.01) by YC treatment, and the lowest (p\<0.01) in VE treatment ([Table 6](#t6-ajas-29-6-814){ref-type="table"}). There was no difference (p = 0.382) on plasma MDA concentration during thermo-neutral period between VE and YC treatments, but the VE treatment was lower (p\<0.01) than the control treatment ([Table 6](#t6-ajas-29-6-814){ref-type="table"}).

DISCUSSION
==========

Yeast culture and vitamin E supplementation on feed intake, rectum temperature and respiration frequency
--------------------------------------------------------------------------------------------------------

One of the most noticeable consequences of HS is to reduce feed intake ([@b1-ajas-29-6-814]). Many studies with dairy cows ([@b29-ajas-29-6-814]; [@b5-ajas-29-6-814]; [@b31-ajas-29-6-814]) reported that YC supplementation increased feed intake during HS. Furthermore, [@b26-ajas-29-6-814] reported that VE supplementation increased feed intake of quail during HS. However, feed intake of the heat stressed dairy goats was not significantly affected by the supplementation of YC and VE in the present study. No study on the effect of YC and VE supplementation on feed intake of dairy goats has been previously reported.

In this study, rectum temperature and respiration frequency of goats increased during HS, which was in accordance with [@b8-ajas-29-6-814]. Researches on dairy cows revealed that the supplementation of YC ([@b5-ajas-29-6-814]) and other fungal cultures ([@b19-ajas-29-6-814]; [@b12-ajas-29-6-814]; [@b16-ajas-29-6-814]) decreased rectum temperature and respiration frequency during HS. Research on poultry revealed that the high dosage of VE supplementation (30 mg/kg body weight) significantly decreased rectum temperature ([@b32-ajas-29-6-814]). In addition, [@b37-ajas-29-6-814] reported that the injection of VE once per week (100 IU/rabbit) significantly decreased rectum temperature and respiration frequency of New Zealand rabbits. But this effect was not found in the present study on dairy goats. In present study, the VE intake of the control was above 42 IU/d, and the plasma concentration of VE was 2.52 mg/L. This indicated the animals VE nutrition status in the control was adequate. Although VE and YC supplementation did not decrease rectum temperature and respiration frequency of dairy goats during HS, the supplementation may help with the rehabilitation of rectum temperature and respiration frequency when ambient temperature decreased to thermo-neutral zone.

Yeast culture and vitamin E supplementation on plasma flux rate and endotoxin absorption
----------------------------------------------------------------------------------------

Plasma flux rate in the 3 treatments decreased with the prolonged HS, whereas it increased significantly when temperature dropped from 35°C to 24°C. These results were in agreement with [@b22-ajas-29-6-814]. Results from the present study showed that the supplementation of VE or YC did not significantly affect the plasma flux in portal vein of dairy goats during HS. It should be noticed that the endotoxin concentration in portal vein and carotid, and that the endotoxin absorption in portal vein in the 3 treatments increased significantly from 20:00 to 21:00 when the temperature decreased from 35°C to 24°C. This could be due to the phenomenon of ischemia reperfusion injury, which refers to the functional damage of an organ caused by blood reperfusion after ischemia. The plasma flux rate in portal vein in goats during HS was 70 L/h, which was in line with [@b33-ajas-29-6-814], who reported 1,047 to 1,290 mL/min in Alpine goats. When the temperature dropped from 35°C to 24°C, blood flux rehabilitated to 100 L/h in present study, an increase of more than 40%. It was recently reported that the mesenteric ischemia--reperfusion induced oxidative injury of the ileum ([@b30-ajas-29-6-814]). The authors suspected that blood reperfusion further led to the injury of intestinal tract, and the damage of intestinal tract led to the increased permeability ([@b13-ajas-29-6-814]), and this incurred the increased absorption of endotoxin. It was proven that endotoxin absorption increased during HS ([@b7-ajas-29-6-814]), which was not confirmed in the present study. It seemed that the average concentration of endotoxin in the portal vein and carotid of the goats was affected by dietary treatments, rather than HS. The amount of endotoxin absorption in portal vein and endotoxin concentration in portal vein and carotid was always the lowest in the VE treated and greatest in the control both in HS period and in thermo-neutral period, indicating that VE supplementation prevented endotoxin absorption.

Yeast culture and vitamin E supplementation on plasma antioxidants
------------------------------------------------------------------

The lowest TAP concentration and the greatest MDA concentration in the 3 treatments in the present study were attained during a narrow time slot from 20:00 to 21:00 when ambient temperature dropped from 35°C to 24°C, which indicated the increased oxidative stress occurred during this period. This could also be caused by ischemia reperfusion as [@b17-ajas-29-6-814] proved that ischemia reperfusion may lead to oxidative injury.

VE supplementation significantly increased the plasma TAP concentration, while significantly decreased plasma MDA concentration of dairy goats during HS and thermo-neutral periods, which meant that VE supplementation effectively strengthened the antioxidant capacity of dairy goats. VE exerts antioxidant function by breaking the free radical reaction chain ([@b36-ajas-29-6-814]). There was no report on the effect of VE supplementation on antioxidants of goat, however, a report on poultry indicated that plasma concentration of MDA decreased during HS when VE was supplemented ([@b26-ajas-29-6-814]). YC supplementation only decreased plasma MDA concentration, but did not increase plasma TAP concentration during HS and thermo-neutral periods, which meant that YC was less powerful than VE in alleviating oxidative stress. It was surprising that VE and YC supplementation lead to decreased plasma SOD concentration during HS. This was possibly attributed by the greater amount of endotoxin absorption in the control which depleted antioxidants and induced the compensatory expression of *SOD* gene ([@b6-ajas-29-6-814]). After 3 h of ischemia reperfusion, plasma SOD concentration in portal vein in VE and YC treatments, but not in the control, increased significantly. These results reflected the alleviation of oxidative stress when VE or YC was supplemented.

CONCLUSION
==========

The portal vein plasma flux rate of heat stressed dairy goats is decreased, which leads to the increase of endotoxin absorption, and thereby decreasing the antioxidant capacity. The supplementation of VE and YC reduces the absorption of endotoxin and effectively strengthens the antioxidant capacity of dairy goats, and hence alleviates HS. Compared to YC, VE is much more powerful in preventing endotoxin absorption and promoting antioxidant capacity.
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###### 

Ingredients and nutrient content of the basal diet fed to goats

  Items                                                                g/100 g
  -------------------------------------------------------------------- ---------
  Ingredients                                                          
   Oat hay                                                             50.0
   Corn                                                                20.0
   Wheat bran                                                          15.0
   Soybean meal                                                        8.0
   Rapeseed meal                                                       4.5
   Calcium carbonate                                                   0.8
   Dicalcium phosphate                                                 0.1
   Salt                                                                0.5
   Sodium bicarbonate                                                  1.0
   Premix[1](#tfn2-ajas-29-6-814){ref-type="table-fn"}                 0.1
  Nutrition level, dry matter basis                                    
   NE~L~ (MJ/kg)                                                       5.52
   CP (%)                                                              12.6
   Ca (%)                                                              0.55
   Tp (%)                                                              0.32
   VE[2](#tfn3-ajas-29-6-814){ref-type="table-fn"} (IU/kg)             28.7
   Concentrate/roughage[3](#tfn3-ajas-29-6-814){ref-type="table-fn"}   51:49

NE~L~, net energy for lactation; CP, crude protein; Ca, Calcium; Tp, total phosphorus; VE, vitamin E.

Premix contained FeSO~4~·7H~2~O 170 g/kg; CuSO~4~·5H~2~O 70 g/kg; MnSO~4~·5H~2~O 290 g/kg; ZnSO~4~·7H~2~O 240 g/kg; CoCl~2~·6H~2~O 510 mg/kg; KI 220 mg/kg; Na~2~SeO~3~ 130 mg/kg; vitamin A 1, 620,000 IU/kg; vitamin D~3~ 324,000 IU/kg; vitamin E 540 IU/kg.

VE concentration and ratio of concentrate to roughage was determined, and all the other parameters were calculated.

###### 

Dry mater intake of the goats in different treatments

  Item         Treatments               
  ------------ ------------ ----------- -----------
  DMI (kg/d)   1.52±0.06    1.60±0.09   1.51±0.08

VE, vitamin E; YC, yeast culture; DMI, dry matter intake.

###### 

Average rectum temperature and respiration frequency of the goats in different treatments and in different periods

  Item                                Treatments                                                                                                           
  ----------------------------------- ---------------------------------------------------------- --------------------------------------------------------- -----------------------------------------------------------
  Rectum temperature (°C)                                                                                                                                  
   Average in heat stress period      40.72±0.06                                                 40.61±0.04                                                40.67±0.02
   Average in thermo-neutral period   39.93±0.09 [a](#tfn6-ajas-29-6-814){ref-type="table-fn"}   39.21±0.26[b](#tfn6-ajas-29-6-814){ref-type="table-fn"}   39.41±0.17 [ab](#tfn6-ajas-29-6-814){ref-type="table-fn"}
   Average of whole period            40.33±0.18                                                 39.91±0.33                                                40.04±0.29
  Respiration frequency (times/min)                                                                                                                        
   Average in heat stress period      133.11±0.11                                                134.89±1.47                                               133.89±0.48
   Average in thermo-neutral period   67.67±3.50                                                 60.11±2.70                                                60.56±4.47
   Average of whole period            100.39±14.72                                               97.50±16.78                                               97.22±16.52

VE, vitamin E; YC, yeast culture.

Means within a row without a similar superscript are different (p\<0.05).

###### 

The rate of plasma flux of the goats in different treatments and in different periods

  Item                             Treatments                                                                                                          
  -------------------------------- --------------------------------------------------------- --------------------------------------------------------- ---------------------------------------------------------
  Heat stress period (L/h)         74.24±2.04[a](#tfn8-ajas-29-6-814){ref-type="table-fn"}   73.50±1.98[a](#tfn8-ajas-29-6-814){ref-type="table-fn"}   74.35±1.19[a](#tfn8-ajas-29-6-814){ref-type="table-fn"}
  Thermo-neutral period (L/h)      98.54±0.69[b](#tfn8-ajas-29-6-814){ref-type="table-fn"}   98.31±0.74[b](#tfn8-ajas-29-6-814){ref-type="table-fn"}   98.02±0.71[b](#tfn8-ajas-29-6-814){ref-type="table-fn"}
  Whole experimenta period (L/h)   86.39±3.80[b](#tfn8-ajas-29-6-814){ref-type="table-fn"}   85.90±3.87[b](#tfn8-ajas-29-6-814){ref-type="table-fn"}   86.18±3.63[b](#tfn8-ajas-29-6-814){ref-type="table-fn"}

VE, vitamin E; YC, yeast culture.

Means within column without a similar superscript are different (p\<0.05).

###### 

The average concentration of endotoxin in carotid and portal vein, and the average absorption of endotoxin in portal vein

  Item                                                          Treatments                                                                                                            
  ------------------------------------------------------------- ---------------------------------------------------------- ---------------------------------------------------------- ----------------------------------------------------------
  Average endotoxin concentration in carotid (EU/mL)                                                                                                                                  
   Heat stress period                                           0.63±0.04[c](#tfn10-ajas-29-6-814){ref-type="table-fn"}    0.43±0.02[a](#tfn10-ajas-29-6-814){ref-type="table-fn"}    0.52±0.01[b](#tfn10-ajas-29-6-814){ref-type="table-fn"}
   Thermo-neutral period                                        0.55±0.08                                                  0.41±0.07                                                  0.44±0.06
   Whole experiment period                                      0.59±0.04[c](#tfn10-ajas-29-6-814){ref-type="table-fn"}    0.42±0.03[a](#tfn10-ajas-29-6-814){ref-type="table-fn"}    0.48±0.03[b](#tfn10-ajas-29-6-814){ref-type="table-fn"}
  Average endotoxin concentration in portal vein (EU/mL)                                                                                                                              
   Heat stress period                                           3.98±0.24[c](#tfn10-ajas-29-6-814){ref-type="table-fn"}    2.74±0.12[a](#tfn10-ajas-29-6-814){ref-type="table-fn"}    3.33±0.08[b](#tfn10-ajas-29-6-814){ref-type="table-fn"}
   Thermo-neutral period                                        3.53±0.50                                                  2.60±0.44                                                  2.80±0.37
   Whole experiment period                                      3.76±0.27[c](#tfn10-ajas-29-6-814){ref-type="table-fn"}    2.67±0.22[a](#tfn10-ajas-29-6-814){ref-type="table-fn"}    3.06±0.20[b](#tfn10-ajas-29-6-814){ref-type="table-fn"}
  Average absorption of endotoxin in portal vein (10^4^ EU/h)                                                                                                                         
   Heat stress period                                           24.71±0.84[c](#tfn10-ajas-29-6-814){ref-type="table-fn"}   16.86±0.39[a](#tfn10-ajas-29-6-814){ref-type="table-fn"}   20.83±0.26[b](#tfn10-ajas-29-6-814){ref-type="table-fn"}
   Thermo-neutral period                                        29.24±4.01                                                 21.54±3.56                                                 23.08±2.90
   Whole experiment period                                      26.97±2.07[c](#tfn10-ajas-29-6-814){ref-type="table-fn"}   19.20±1.85[a](#tfn10-ajas-29-6-814){ref-type="table-fn"}   21.95±1.43[b](#tfn10-ajas-29-6-814){ref-type="table-fn"}

VE, vitamin E; YC, yeast culture.

Means within row without a similar superscript are different (p\<0.05).

###### 

The average concentration of plasma antioxidants in different treatments

  Item                       Treatments                                                                                                              
  -------------------------- ----------------------------------------------------------- ----------------------------------------------------------- ------------------------------------------------------------
  SOD (U/mL)                                                                                                                                         
   Heat stress period        113.48±1.98[b](#tfn12-ajas-29-6-814){ref-type="table-fn"}   101.67±1.11[a](#tfn12-ajas-29-6-814){ref-type="table-fn"}   101.51±0.80 [a](#tfn12-ajas-29-6-814){ref-type="table-fn"}
   Thermo-neutral period     111.74±0.82[b](#tfn12-ajas-29-6-814){ref-type="table-fn"}   107.16±1.06[a](#tfn12-ajas-29-6-814){ref-type="table-fn"}   108.36±1.53[ab](#tfn12-ajas-29-6-814){ref-type="table-fn"}
   Whole experiment period   112.61±1.05[b](#tfn12-ajas-29-6-814){ref-type="table-fn"}   104.42±1.10[a](#tfn12-ajas-29-6-814){ref-type="table-fn"}   104.93±1.32[a](#tfn12-ajas-29-6-814){ref-type="table-fn"}
  TAP (EU/mL)                                                                                                                                        
   Heat stress period        1.39±0.03[a](#tfn12-ajas-29-6-814){ref-type="table-fn"}     1.66±0.01[c](#tfn12-ajas-29-6-814){ref-type="table-fn"}     1.51±0.04[b](#tfn12-ajas-29-6-814){ref-type="table-fn"}
   Thermo-neutral period     1.53±0.07[a](#tfn12-ajas-29-6-814){ref-type="table-fn"}     1.85±0.09[b](#tfn12-ajas-29-6-814){ref-type="table-fn"}     1.69±0.12[ab](#tfn12-ajas-29-6-814){ref-type="table-fn"}
   Whole experiment period   1.46±0.04[a](#tfn12-ajas-29-6-814){ref-type="table-fn"}     1.76±0.05[b](#tfn12-ajas-29-6-814){ref-type="table-fn"}     1.60±0.07[a](#tfn12-ajas-29-6-814){ref-type="table-fn"}
  MDA (n mol/mL)                                                                                                                                     
   Heat stress period        2.40±0.06[c](#tfn12-ajas-29-6-814){ref-type="table-fn"}     1.62±0.04[a](#tfn12-ajas-29-6-814){ref-type="table-fn"}     1.94±0.03[b](#tfn12-ajas-29-6-814){ref-type="table-fn"}
   Thermo-neutral period     2.37±0.08[b](#tfn12-ajas-29-6-814){ref-type="table-fn"}     1.44±0.10[a](#tfn12-ajas-29-6-814){ref-type="table-fn"}     1.64±0.09[ab](#tfn12-ajas-29-6-814){ref-type="table-fn"}
   Whole experiment period   2.39±0.05[c](#tfn12-ajas-29-6-814){ref-type="table-fn"}     1.53±0.06[a](#tfn12-ajas-29-6-814){ref-type="table-fn"}     1.79±0.07[b](#tfn12-ajas-29-6-814){ref-type="table-fn"}

VE, vitamin E; YC, yeast culture; SOD, superoxide dismutase; TAP, total antioxidant potential; MDA, malonaldehyde.

Means within row without a similar superscript are different (p\<0.05).
